About 1 result found for searched term "FHD-286" (0.125 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M11416 | FHD-286 | Epigenetic Reader Domain |
| FHD-286 is a BRG1/BRM ATPase inhibitor, which can be used in the study of BAF-related diseases. Fdd-286 is also the first SMARCA2/SMARCA4 dual inhibitor. It can be used in the study of metastatic melanoma and advanced hematologic tumors. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
